Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.63 - $1.14 $15,750 - $28,499
-25,000 Reduced 8.93%
255,010 $211,000
Q3 2023

Nov 14, 2023

SELL
$1.12 - $1.88 $39,704 - $66,646
-35,450 Reduced 11.24%
280,010 $316,000
Q2 2023

Aug 15, 2023

BUY
$1.31 - $2.04 $67,281 - $104,774
51,360 Added 19.45%
315,460 $504,000
Q3 2022

Nov 15, 2022

BUY
$1.96 - $3.14 $138,768 - $222,312
70,800 Added 36.63%
264,100 $541,000
Q2 2022

Aug 15, 2022

BUY
$1.3 - $2.64 $60,450 - $122,760
46,500 Added 31.68%
193,300 $375,000
Q1 2022

May 13, 2022

BUY
$2.35 - $3.47 $940 - $1,388
400 Added 0.27%
146,800 $361,000
Q2 2021

Jul 30, 2021

BUY
$2.56 - $5.49 $64,000 - $137,250
25,000 Added 20.59%
146,400 $804,000
Q1 2021

May 06, 2021

SELL
$2.69 - $5.25 $63,753 - $124,425
-23,700 Reduced 16.33%
121,400 $330,000
Q4 2020

Feb 08, 2021

SELL
$3.17 - $4.49 $70,057 - $99,229
-22,100 Reduced 13.22%
145,100 $461,000
Q3 2020

Nov 12, 2020

SELL
$2.98 - $5.2 $21,158 - $36,920
-7,100 Reduced 4.07%
167,200 $669,000
Q2 2020

Aug 13, 2020

SELL
$2.29 - $4.24 $14,885 - $27,560
-6,500 Reduced 3.6%
174,300 $685,000
Q2 2019

Aug 14, 2019

BUY
$2.53 - $3.04 $4,554 - $5,472
1,800 Added 1.01%
180,800 $542,000
Q1 2019

May 14, 2019

SELL
$2.51 - $3.73 $39,407 - $58,561
-15,700 Reduced 8.06%
179,000 $532,000
Q4 2018

Feb 13, 2019

BUY
$1.59 - $2.66 $41,817 - $69,958
26,300 Added 15.62%
194,700 $463,000
Q3 2018

Nov 08, 2018

BUY
$1.59 - $2.42 $15,741 - $23,958
9,900 Added 6.25%
168,400 $360,000
Q2 2018

Aug 13, 2018

BUY
$2.26 - $4.65 $82,263 - $169,260
36,400 Added 29.81%
158,500 $360,000
Q1 2018

May 14, 2018

SELL
$3.51 - $6.04 $9,828 - $16,912
-2,800 Reduced 2.24%
122,100 $575,000
Q4 2017

Feb 13, 2018

SELL
$3.26 - $4.78 $64,547 - $94,644
-19,800 Reduced 13.68%
124,900 $407,000
Q3 2017

Nov 13, 2017

BUY
$3.48 - $4.44 $503,556 - $642,468
144,700
144,700 $638,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.